Peptide Receptor Radionuclide Therapy Gaining Popularity in Italy Peptide receptor radionuclide therapy, also known as PRRT, is an emerging treatment option for neuroendocrine tumours (NETs) in Italy. This novel form of targeted radiotherapy is showing promising results and is being adopted by more oncology facilities across the country.
PRRT is a type of systemic radiotherapy where small amounts of radioactive substances are attached to peptides that bind to...
0 Shares
1207 Views
0 Reviews